177 related articles for article (PubMed ID: 33612410)
41. Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.
Lorch JH; Hanna GJ; Posner MR; O'Neill A; Thotakura VL; Limaye SA; Rabinowits G; Sher DJ; Tishler RB; Haddad RI
Head Neck; 2016 Apr; 38 Suppl 1():E1618-24. PubMed ID: 26614576
[TBL] [Abstract][Full Text] [Related]
42. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
Albergotti WG; Abberbock S; Mathews F; Ferris RL; Johnson JT; Duvvuri U; Kim S
Head Neck; 2018 Aug; 40(8):1685-1690. PubMed ID: 29756301
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
44. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
45. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
[TBL] [Abstract][Full Text] [Related]
46. Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes.
Mattioli F; Lo Manto A; Miglio M; Serafini E; Rossi D; Valerini S; Tonelli R; Fermi M; Pugliese G; Bertolini F; D'Angelo E; Depenni R; Dominici M; Lohr FRH; Marchioni D
Head Neck; 2023 Jun; 45(6):1406-1417. PubMed ID: 37040549
[TBL] [Abstract][Full Text] [Related]
47. HPV-positive head and neck tumours, a distinct clinical entity.
Nevens D; Nuyts S
B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
[TBL] [Abstract][Full Text] [Related]
48. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
50. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
51. Impact of HPV status on metastatic patterns and survival in non-oropharyngeal head and neck cancer with distant metastasis.
Wang P; Zang S; Zhang M; Li G; Wang Y; Qiao Q
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3029-3039. PubMed ID: 35124745
[TBL] [Abstract][Full Text] [Related]
52. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
[TBL] [Abstract][Full Text] [Related]
53. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
54. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
55. Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.
Huang YH; Yeh CH; Cheng NM; Lin CY; Wang HM; Ko SF; Toh CH; Yen TC; Liao CT; Ng SH
PLoS One; 2017; 12(7):e0180779. PubMed ID: 28686646
[TBL] [Abstract][Full Text] [Related]
56. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
57. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
58. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
Wang MB; Liu IY; Gornbein JA; Nguyen CT
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
[TBL] [Abstract][Full Text] [Related]
59. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
[TBL] [Abstract][Full Text] [Related]
60. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
